Engelhart James
Chief Financial Officer at Biohaven Pharmaceutical Holding Co Ltd.
- Sold, on record
- $9.9M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Dec 10, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Biohaven Pharmaceutical Holding Co Ltd.Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualNov 10, 2017 2017
Sold 30,538 shares at $26.58 ($812k)
Engelhart James, Chief Financial Officer
Sold 89.5% of holdings ($907k position)3,576 shares leftFirst sale on recordFiling
- 2 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualJan 22, 2018 +73 days
Sold 10,000 shares at $32.50 ($325k)
Engelhart James, Chief Financial Officer
Sold 73.7% of holdings ($441k position)3,576 shares leftFiling
- 3 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not statedFeb 21, 2018 +30 days
Sold 538 shares at $29.60 ($16k)
Engelhart James, Chief Financial Officer
Sold 15% of holdings ($106k position)3,038 shares leftFiling
- 4 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualMay 7, 2018 +75 days
Sold 2,500 shares at $27.67 ($69k)
Engelhart James, Chief Financial Officer
Sold 100% of holdings ($69k position)0 shares left0.3x usual sizeFiling
- 5 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualMay 30, 2018 +23 days
Sold 5,000 shares at $35.00 ($175k)
Engelhart James, Chief Financial Officer
Sold 100% of holdings ($175k position)0 shares left0.8x usual sizeFiling
- 6 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualJun 11, 2020 +743 days
Sold 73,725 shares at $66.09 ($4.9M)
Engelhart James, Chief Financial Officer
Sold 94.2% of holdings ($5.2M position)4,522 shares leftFirst sale on recordFiling
- 7 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualDec 10, 2021 +547 days
Sold 35,000 shares at $102.55 ($3.6M)
Engelhart James, Chief Financial Officer
Sold 75.8% of holdings ($4.7M position)11,196 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2021 | Dec 10, 2021 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Financial Officer | Form 4 sale | 35,000 | $3.6M | 75.8% | Unusual | SEC |
| Jun 11, 2020 | Jun 12, 2020 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Financial Officer | Form 4 sale | 73,725 | $4.9M | 94.2% | Unusual | SEC |
| May 30, 2018 | May 30, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Financial Officer | Form 4 sale | 5,000 | $175k | 100.0% | Unusual | SEC |
| May 7, 2018 | May 9, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Financial Officer | Form 4 sale | 2,500 | $69k | 100.0% | Unusual | SEC |
| Feb 21, 2018 | Feb 23, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Financial Officer | Form 4 sale | 538 | $16k | 15.0% | Plan not stated | SEC |
| Jan 22, 2018 | Jan 24, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Financial Officer | Form 4 sale | 10,000 | $325k | 73.7% | Unusual | SEC |
| Nov 10, 2017 | Nov 14, 2017 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Financial Officer | Form 4 sale | 30,538 | $812k | 89.5% | Unusual | SEC |